儿童可除颤院内心脏骤停中除颤前使用肾上腺素的情况
该回顾性队列研究利用2000-2020年美国心脏协会Get With the Guidelines-Resuscitation登记数据,纳入492例初始心律为室颤或无脉性室速且至少尝试一次除颤的儿童(<18岁)院内心脏骤停指数事件,中位年龄7岁,351例(71%)在ICU。主要暴露为除颤前或同一分钟给予肾上腺素,232例(47%)符合(除颤前29%、同一分钟18%)。未校正分析中,暴露组出院生存(37.1% vs 51.2%)、ROSC(74.6% vs 84.6%)及良好神经预后(22.1% vs 40.4%)均低于未暴露组;但倾向性评分匹配(对除颤时间类别精确匹配)校正后,肾上腺素与出院生存(OR 0.84,0.46-1.56)、ROSC(OR 0.97,0.48-1.96)及良好神经预后(OR 0.52,0.27-1.00)均无统计学显著关联。作者指出,与当前指南相反,近50%初始可除颤心律的儿童院内心脏骤停在首次除颤前或同一分钟接受了肾上腺素;尽管暴露组生存结局数值上更低,但关联无统计学显著性。
要点
- 492例初始可除颤心律的儿童院内心脏骤停中,232例(47%)在除颤前(29%)或同一分钟(18%)接受肾上腺素。
- 未校正分析中,暴露组出院生存37.1% vs 未暴露组51.2%,ROSC 74.6% vs 84.6%,良好神经预后22.1% vs 40.4%,均数值更低。
- 倾向性评分匹配(对除颤时间类别精确匹配)校正后,肾上腺素与出院生存(OR 0.84,0.46-1.56)、ROSC(OR 0.97,0.48-1.96)及良好神经预后(OR 0.52,0.27-1.00)均无统计学显著关联。
- 中位年龄7岁,351例(71%)在ICU发生心脏骤停。
- 作者指出,与当前指南相反,近50%初始可除颤心律的儿童院内心脏骤停在首次除颤前或同一分钟接受了肾上腺素。
适用人群与场景
- 儿童(<18岁)院内心脏骤停指数事件,初始心律为室颤或无脉性室速,且至少尝试一次除颤。
- 数据来源为2000-2020年美国心脏协会Get With the Guidelines-Resuscitation登记,中位年龄7岁,351例(71%)在ICU。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用2000-2020年美国心脏协会Get With the Guidelines-Resuscitation登记数据。
- 样本量:492例儿童(<18岁)院内心脏骤停指数事件,初始心律为室颤或无脉性室速且至少一次除颤尝试;中位年龄7岁,351例(71%)在ICU。
- 主要暴露:除颤前或同一分钟给予肾上腺素;232例(47%)符合,其中除颤前29%、同一分钟18%。
- 未校正分析:暴露组 vs 未暴露组出院生存37.1% vs 51.2%,ROSC 74.6% vs 84.6%,良好神经预后22.1% vs 40.4%,暴露组均更低。
- 倾向性评分匹配(对除颤时间类别精确匹配)校正后:出院生存OR 0.84(95%CI 0.46-1.56),ROSC OR 0.97(95%CI 0.48-1.96),良好神经预后OR 0.52(95%CI 0.27-1.00),均无统计学显著关联。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者指出,与当前指南相反,近50%初始可除颤心律的儿童院内心脏骤停在首次除颤前或同一分钟接受了肾上腺素;尽管暴露组生存结局数值上更低,但校正后关联无统计学显著性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Assess prevalence of epinephrine before or during the same minute as defibrillation and association with clinical outcomes in pediatric in-hospital cardiac arrest (IHCA).
DESIGN: Retrospective cohort study.
SETTING: We used 2000-2020 data from the American Heart Association's Get With the Guidelines-Resuscitation Registry.
PATIENTS: Children (< 18 yr) with index IHCA with an initial shockable rhythm of ventricular fibrillation or pulseless ventricular tachycardia and at least one defibrillation attempt.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The primary exposure was epinephrine administration before or during the same minute as defibrillation. Study outcomes were survival to hospital discharge (primary outcome), return of spontaneous circulation (ROSC) for greater than or equal to 20 min, and survival with favorable neurologic outcome. Propensity-score matching was used for confounding adjustment. Among 492 pediatric IHCA index events with an initial shockable rhythm, median age was 7 years and 351 (71%) were in the ICU. Overall, 232 (47%) children received either epinephrine before defibrillation (29%) or during the same minute as defibrillation (18%). In unadjusted analyses, proportions of survival to hospital discharge (37.1% vs. 51.2%), ROSC (74.6% vs. 84.6%), and survival with favorable neurologic outcome (22.1% vs. 40.4%) were lower in the epinephrine before or during the same minute as defibrillation group. However, in adjusted analyses using propensity score matching with exact matching on time to defibrillation category, epinephrine before or during the same minute as defibrillation was not associated with hospital survival (odds ratio [OR] 0.84, 0.46-1.56), ROSC (OR 0.97, 0.48-1.96), or favorable neurologic outcome (OR 0.52, 0.27-1.00).
CONCLUSIONS: Contrary to current guidelines, nearly 50% of pediatric IHCA due to an initial shockable rhythm receive epinephrine before, or during the same minute, as first defibrillation. Although survival outcomes were numerically lower in epinephrine before defibrillation group, the association was not statistically significant.
参考来源
- Swanson MB, Lasa JJ, Chan PS, et al. Epinephrine Before Defibrillation in Children With Initially Shockable In-Hospital Cardiac Arrest. Crit Care Med. 2025. PMID: 40736349. doi:10.1097/CCM.0000000000006804
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。